Physicians' Desk Reference |
From inside the book
Results 1-3 of 81
Page 347
... ACID - MODIFIED MEDICAL FOOD WITH IRON ( Ross ) . SUSPENSION ( Wallace ) ...... 341 , 3159 RYNATUSS TABLETS ( Wallace ) .. ACES Antioxidant Soft Gels ( Carlson ) .... 899 SELENIUM SULFIDE 341 , 3160 2702 RYNATUSS PEDIATRIC RIMACTANE ...
... ACID - MODIFIED MEDICAL FOOD WITH IRON ( Ross ) . SUSPENSION ( Wallace ) ...... 341 , 3159 RYNATUSS TABLETS ( Wallace ) .. ACES Antioxidant Soft Gels ( Carlson ) .... 899 SELENIUM SULFIDE 341 , 3160 2702 RYNATUSS PEDIATRIC RIMACTANE ...
Page 426
... Acid ) WARNING : HEPATIC FAILURE RESULTING IN FATALITIES HAS OCCURRED IN PATIENTS RECEIVING VALP- ROIC ACID . EXPERIENCE HAS INDICATED THAT CHILDREN UNDER THE AGE OF TWO YEARS ARE AT A CONSIDERABLY INCREASED RISK OF DE- VELOPING FATAL ...
... Acid ) WARNING : HEPATIC FAILURE RESULTING IN FATALITIES HAS OCCURRED IN PATIENTS RECEIVING VALP- ROIC ACID . EXPERIENCE HAS INDICATED THAT CHILDREN UNDER THE AGE OF TWO YEARS ARE AT A CONSIDERABLY INCREASED RISK OF DE- VELOPING FATAL ...
Page 449
... acid . Each Filmtab tablet provides : 525 mg * Ferrous Sulfate ( equivalent to 105 mg of elemental iron ) Ascorbic Acid ( present as sodium ascorbate ) ( C ) Niacinamide 500 mg 30 mg 10 mg Calcium Pantothenate 6 mg 6 mg 5 mg 800 mcg 25 ...
... acid . Each Filmtab tablet provides : 525 mg * Ferrous Sulfate ( equivalent to 105 mg of elemental iron ) Ascorbic Acid ( present as sodium ascorbate ) ( C ) Niacinamide 500 mg 30 mg 10 mg Calcium Pantothenate 6 mg 6 mg 5 mg 800 mcg 25 ...
Other editions - View all
Common terms and phrases
acid Actiq adverse events ADVERSE REACTIONS AstraZeneca barbiturates baseline blood Bristol-Myers Bristol-Myers Squibb cancer Caplets Capsules carteolol cefotetan Chewable chloride clarithromycin clearance clinical trials concentrations CONTRAINDICATIONS Cream daily dose decrease DEPAKOTE DIPRIVAN DIPRIVAN Injectable Emulsion discontinued disease DOSAGE AND ADMINISTRATION DOXIL effects EPOGEN erythromycin excreted fenofibrate GABITRIL GLAXO WELLCOME GLAXO WELLCOME INC hepatic human Hydrochloride impaired increased INDICATIONS AND USAGE Infergen infusion Inhalation intravenous LABORATORIES levels liver McNeil Consumer Medical Merck meropenem metabolism mg/day mg/kg mg/kg/day mg/m² mg/mL monitored NEUPOGEN Novartis occur Ointment Oral Solution overdosage pain patients receiving Pediatric PHARMACEUTICALS pharmacokinetics phenobarbital placebo plasma potassium potential Pregnancy Products Described rats recommended renal reported respiratory ritonavir seizures serum skin SmithKline Beecham sodium Sterile studies sulfate symptoms Syrup System Tablets terazosin TESTODERM therapeutic therapy tiagabine tients tion treatment Tylenol valproate valproic acid vial VIRACEPT vitro Wyeth-Ayerst ZYFLO µg/mL